Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Onumara Opara

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The American Journal on Addictions|June 8, 2025
Factors associated with receipt of second injection of naltrexone for opioid use disorder: Secondary analysis of 5 clinical trialsMatisyahu Shulman, Mei-Chen Hu, Maria A Sullivan, et al.
Clinical Transplantation|March 14, 2019
Alemtuzumab induction and belatacept maintenance in marginal pathology renal allograftsTracy Sparkes, Bharath Ravichandran, Onumara Opara, et al.
Nutrition and Metabolic Insights|March 14, 2020
Social Network Intervention Reduces Added Sugar Intake Among Baltimore Public Housing Residents: A Feasibility StudyKimberly A Gudzune, Onumara Opara, Jonathan C Martinez, et al.
Journal of Addiction Medicine|August 14, 2023
Homelessness and Treatment Outcomes Among Black Adults With Opioid Use Disorder: A Secondary Analysis of X:BOTMarissa Justen, Jennifer Scodes, Martina Pavlicova, et al.
Substance Use & Misuse|August 17, 2022
Patient Characteristics Associated with Opioid Abstinence after Participation in a Trial of Buprenorphine versus Injectable NaltrexoneMiranda G Greiner, Matisyahu Shulman, Jennifer Scodes, et al.
JAMA Network Open|May 8, 2024
Rapid Initiation of Injection Naltrexone for Opioid Use Disorder: A Stepped-Wedge Cluster Randomized Clinical TrialMatisyahu Shulman, Miranda G Greiner, Hiwot M Tafessu, et al.
Contemporary Clinical Trials|March 17, 2023
Surmounting Withdrawal to Initiate Fast Treatment with Naltrexone (SWIFT): A stepped wedge hybrid type 1 effectiveness-implementation studyMiranda G Greiner, Matisyahu Shulman, Onumara Opara, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The American Journal on Addictions|June 8, 2025
Factors associated with receipt of second injection of naltrexone for opioid use disorder: Secondary analysis of 5 clinical trialsMatisyahu Shulman, Mei-Chen Hu, Maria A Sullivan, et al.
Clinical Transplantation|March 14, 2019
Alemtuzumab induction and belatacept maintenance in marginal pathology renal allograftsTracy Sparkes, Bharath Ravichandran, Onumara Opara, et al.
Nutrition and Metabolic Insights|March 14, 2020
Social Network Intervention Reduces Added Sugar Intake Among Baltimore Public Housing Residents: A Feasibility StudyKimberly A Gudzune, Onumara Opara, Jonathan C Martinez, et al.
Journal of Addiction Medicine|August 14, 2023
Homelessness and Treatment Outcomes Among Black Adults With Opioid Use Disorder: A Secondary Analysis of X:BOTMarissa Justen, Jennifer Scodes, Martina Pavlicova, et al.
Substance Use & Misuse|August 17, 2022
Patient Characteristics Associated with Opioid Abstinence after Participation in a Trial of Buprenorphine versus Injectable NaltrexoneMiranda G Greiner, Matisyahu Shulman, Jennifer Scodes, et al.
JAMA Network Open|May 8, 2024
Rapid Initiation of Injection Naltrexone for Opioid Use Disorder: A Stepped-Wedge Cluster Randomized Clinical TrialMatisyahu Shulman, Miranda G Greiner, Hiwot M Tafessu, et al.
Contemporary Clinical Trials|March 17, 2023
Surmounting Withdrawal to Initiate Fast Treatment with Naltrexone (SWIFT): A stepped wedge hybrid type 1 effectiveness-implementation studyMiranda G Greiner, Matisyahu Shulman, Onumara Opara, et al.
Pageof 1